Clinical Trials: Soft Tissue Infections

Alabama

Birmingham; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Mobile; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Florida

Miami Beach; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Michigan

Detroit; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Minnesota

Minneapolis; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

North Carolina

Winston-Salem; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

International

Buenos Aires , Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Ciudadela, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Córdoba, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Granadero Baigorria, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Neuquen, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Palomar, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Parana, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Rosario, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Santa Fe, Argentina; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Pleven, Bulgaria; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Plovdiv, Bulgaria; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Sofia, Bulgaria; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Varna, Bulgaria; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Tallinn, Estonia; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Tartu, Estonia; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Lübeck, Germany; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Mainz, Germany; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

München, Germany; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Budapest, Hungary; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Liepaja, Latvia; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Riga, Latvia; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Kaunas, Lithuania; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Klaipeda, Lithuania; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Vilnius, Lithuania; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Lima, Peru; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Bucharest, Romania; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Cluj-Napoca, Romania; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Constanta, Romania; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Tirgu-Mures, Romania; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Benoni, South Africa; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Cape Town, South Africa; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Middleburg, South Africa; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Port Elizabeth, South Africa; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Pretoria, South Africa; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Sommerset West, South Africa; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Temba, South Africa; Research Site:
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

International Listings

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: July 21, 2008 at 3:48:04 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA